These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8286845)
1. Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis. Kobayashi T; Kobayashi M; Naka M; Nakajima K; Momose A; Toi M Intern Med; 1993 Jul; 32(7):607-9. PubMed ID: 8286845 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of prokinetic-resistant intestinal pseudo-obstruction and pneumatosis cystoides intestinalis in systemic sclerosis with metronidazole. Fujita M; Nakano Y; Yagita M Rheumatol Int; 2017 Jul; 37(7):1213-1215. PubMed ID: 28213637 [No Abstract] [Full Text] [Related]
3. Intestinal pseudo-obstruction and pneumatosis cystoides intestinalis in a scleroderma patient. Seket B; Kaczmarek D; Tiffet O J Am Coll Surg; 2007 Jul; 205(1):180-1. PubMed ID: 17617347 [No Abstract] [Full Text] [Related]
4. Pneumatosis cystoides intestinalis in scleroderma-related conditions. Balbir-Gurman A; Brook OR; Chermesh I; Braun-Moscovici Y Intern Med J; 2012 Mar; 42(3):323-9. PubMed ID: 22432985 [TBL] [Abstract][Full Text] [Related]
5. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Verne GN; Eaker EY; Hardy E; Sninsky CA Dig Dis Sci; 1995 Sep; 40(9):1892-901. PubMed ID: 7555439 [TBL] [Abstract][Full Text] [Related]
6. Pneumatosis cystoides intestinalis in progressive systemic sclerosis: a case report and literature review. Quiroz ES; Flannery MT; Martinez EJ; Warner EA Am J Med Sci; 1995 Dec; 310(6):252-5. PubMed ID: 7503106 [TBL] [Abstract][Full Text] [Related]
7. [A case of pneumatosis cystoides intestinalis and intestinal pseudo-obstruction in overlap syndrome manifested by polymyositis and scleroderma]. Sawamura N; Ishiguro Y; Yamagata K; Kawaguchi S; Yoshimura T; Mikami T; Sasaki Y; Fukuda S; Munakata A Nihon Shokakibyo Gakkai Zasshi; 2005 Jun; 102(6):706-11. PubMed ID: 15981628 [No Abstract] [Full Text] [Related]
8. Chronic intestinal pseudo-obstruction with pneumatosis cystoides intestinalis in a patient with systemic sclerosis: A case report. Mitsuyoshi Y; Takakura K; Kobayashi T; Ogawa N; Sakurai T; Nakano M; Ukichi T; Ishiuji Y; Torisu Y; Saruta M Medicine (Baltimore); 2019 May; 98(18):e15480. PubMed ID: 31045831 [TBL] [Abstract][Full Text] [Related]
9. Pneumatosis cystoides intestinalis in intestinal pseudoobstruction. Resolution after therapy with metronidazole. Tak PP; Van Duinen CM; Bun P; Eulderink F; Kreuning J; Gooszen HG; Lamers CB Dig Dis Sci; 1992 Jun; 37(6):949-54. PubMed ID: 1587203 [TBL] [Abstract][Full Text] [Related]
10. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide. Lanting PJ; Kruijsen MW; Rasher JJ; van den Hoogen FH; Boerbooms AM; van de Putte LB J Rheumatol; 1993 Dec; 20(12):2175. PubMed ID: 8014959 [No Abstract] [Full Text] [Related]
11. [Octreotide in intestinal pseudo-obstruction?]. Layer P; Holtmann G Z Gastroenterol; 1992 May; 30(5):346-7. PubMed ID: 1632118 [No Abstract] [Full Text] [Related]
12. [Systemic sclerosis with various gastrointestinal problems including pneumoperitoneum, pneumatosis cystoides intestinalis and malabsorption syndrome]. Satoh A; Hoshina Y; Shimizu H; Morita K; Uchiyama M; Moriuchi J; Takaya M; Ichikawa Y Ryumachi; 1995 Dec; 35(6):927-33. PubMed ID: 8720272 [TBL] [Abstract][Full Text] [Related]
13. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. Soudah HC; Hasler WL; Owyang C N Engl J Med; 1991 Nov; 325(21):1461-7. PubMed ID: 1944424 [TBL] [Abstract][Full Text] [Related]
14. [Five cases of systemic sclerosis with associated with intestinal pseudo-obstruction]. Ishikawa M; Okada J; Kondo H Ryumachi; 1999 Oct; 39(5):768-73. PubMed ID: 10614172 [TBL] [Abstract][Full Text] [Related]
15. [Paralytic ileus, pneumatosis cystoides intestinalis and pneumoperitoneum complicated with overlap syndrome (progressive systemic sclerosis and polymyositis): report of an autopsy case]. Shiroko J; Yoshikawa T; Ohnishi T; Nakai M; Asano H; Kawakami T; Tanabashi S; Kametani M; Okamoto K Nihon Shokakibyo Gakkai Zasshi; 2000 Aug; 97(8):1031-7. PubMed ID: 10965761 [No Abstract] [Full Text] [Related]
16. Octreotide in gastrointestinal motility disorders. Owyang C Gut; 1994; 35(3 Suppl):S11-4. PubMed ID: 8206395 [TBL] [Abstract][Full Text] [Related]
17. Advanced scleroderma bowel: complications and management. Stafford-Brady FJ; Kahn HJ; Ross TM; Russell ML J Rheumatol; 1988; 15(5):869-74. PubMed ID: 3172104 [TBL] [Abstract][Full Text] [Related]
18. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin]. Lecomte T; Cavicchi M; Delchier JC Gastroenterol Clin Biol; 2000 Mar; 24(3):361-3. PubMed ID: 10804347 [TBL] [Abstract][Full Text] [Related]
19. Pneumatosis cystoides intestinalis (PCI) in a patient with undiagnosed systemic sclerosis. Singh G; Johnson C; Gill R; De Cruz P BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30269087 [TBL] [Abstract][Full Text] [Related]